New study tests simple blood thinner to protect new moms from deadly clots
NCT ID NCT07140211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether giving new mothers a low-dose blood thinner for just 7-10 days after delivery can prevent blood clots in the legs or lungs. About 9,200 women with certain risk factors (like emergency C-section, obesity, or pre-eclampsia) will either receive the drug or no treatment. The goal is to see if this short-term approach reduces clot risk without causing serious bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Geneva University Hospitals
RECRUITINGGeneva, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••